Please use this identifier to cite or link to this item:
Full metadata record
DC FieldValueLanguage
dc.contributor.authorCortés Garcia, Juan Diego-
dc.contributor.authorLópez López, Cintya-
dc.contributor.authorCortez Espinosa, Nancy-
dc.contributor.authorGarcía Hernández, Mariana H.-
dc.contributor.authorGuzmán Flores, Juan Manuel-
dc.contributor.authorLayseca Espinosa, Esther-
dc.contributor.authorPortales Cervantesa, Liliana-
dc.contributor.authorPortales Pérez, Diana Patricia-
dc.identifier.citationCortés-Garcia JD, López-López C, Cortez-Espinosa N, García-Hernández MH, Guzmán-Flores JM, Layseca-Espinosa E., Portales-Cervantes L, Portales-Pérez DP. Evaluation of the expression and function of the P2X7 receptor and ART1 in human regulatory T-cell subsets. Immunobiology. 2016 Jan;221(1):84-93. doi: 10.1016/j.imbio.2015.07.018. Epub 2015 Jul, en
dc.description.abstractRegulatory T cells that express CD39 (CD39+ Treg) exhibit specific immunomodulatory properties. Ectonucleotidase CD39 hydrolyses ATP and ADP. ATP is a ligand of the P2X7 receptor and induces the shedding of CD62L and apoptosis. However, the role of ATP in CD39+ Treg cells has not been defined. Furthermore, NAD can activate the P2X7 receptor via ADP-ribosyltransferase (ART) enzymes and cause cell depletion in murine models. We evaluated the expression and function of P2X7 and ART1 in CD39+ Treg and CD39- Treg cells in the presence or absence of ATP and NAD. We isolated peripheral blood mononuclear cells from healthy subjects and purified CD4+ T cells, CD4+ CD25+ T cells and CD4+ CD25+ CD39+ T cells. P2X7 and ART1 expression was assessed by flow cytometry and real-time PCR. Our results showed low P2X7 expression on CD39+ Treg cells and higher levels of ART1 expression in CD4+ CD39+ T cells than the other subtypes studied. Neither shedding of CD62L nor cell death of CD39+ Treg or CD39- Treg cells was observed by 1mM ATP or 60μM NAD. In contrast, P2Xs receptor-dependent proliferation with 300μM ATP, was inhibited by NAD in the different cell types analysed. The NAD proliferation-inhibition was increased with P2Xs and A2a agonist and was reversed with P2Xs and A2a antagonist, therefore NAD inhibits P2Xs-dependent proliferation and A2a activation. In conclusion, our results suggest that the altered function and expression of P2X7 and ART1 in the human CD39+ Treg or CD39- Treg cells could participate in the resistance against cell death induced by ATP or, en
dc.description.sponsorshipLaboratory of Immunology and Cellular and Molecular Biology, Faculty of Chemical Sciences, UASLP, San Luis Potosí, S.L.P., Mexico Division of Molecular Biology, Instituto Potosino de Investigación Científica y Tecnológica, San Luis Potosí, S.L.P. Mexico Unit of Medicine Investigation IMSS, Zacatecas, Zac, Mexico Department of Immunology, Faculty of Medicine, UASLP, San Luis Potosí, S.L.P. Mexicoes, en
dc.language.isoenes, en
dc.publisherElsevier GmbHes, en
dc.relation.ispartofseriesImmunobiology.;Vol. 221. Número1. Pags. 84-93-
dc.subjectP2X7 receptores, en
dc.subjectART1es, en
dc.subjectATPes, en
dc.subjectNADes, en
dc.subjectimmune regulationes, en
dc.subjectCD39es, en
dc.titleEvaluation of the expression and function of the P2X7 receptor and ART1 in human regulatory T-cell subsetses, en
dc.typeArticlees, en
Appears in Collections:2412 Artículos

Files in This Item:
File Description SizeFormat 
Enlace a_Evaluation of the expression .htmEnlace a artículo40.66 kBHTMLView/Open
Enlace a publicación_Inmuobiology2016_221_1.htmEnlace a publicación42.58 kBHTMLView/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.